Skip to content

State at other companies

Huntington Ingalls Industries logo
Huntington Ingalls IndustriesHII
-$4M-300%
Williams Companies logo
Williams CompaniesWMB
$256M+22.5%
Wintrust Financial logo
Wintrust FinancialWTFC
$702.25K+567%
Antero Resources logo
Antero ResourcesAR
-$25.57M-236%
Carrier Global logo
Carrier GlobalCARR
$374M-1.8%
Two Harbors Investment Corporation logo
Two Harbors Investment CorporationTWO

Other financials

Income statement

See full
Revenue$246.1M+87.0%
Gross profit$243.1M+86.8%
Operating income-$117.4M+20.0%
Net income-$92.5M+37.0%
EPS (diluted)-$0.56+39.8%

Balance sheet

See full
Cash & equivalents$173.4M-34.4%
Total debt$691.7M+334%
Total equity$491.4M+3.3%
Total assets$3.4B+22.6%

Cash flow

See full
Operating cash flow-$792.8M-426%
CapEx$21.8M+73.0%
Free cash flow-$814.6M-399%

Valuation

See full
Market cap$12.25B+159%
Enterprise value$12.77B+175%
P/S11.6×+5.0×

Profitability

See full
Gross margin98.4%-0.2pp
Operating margin-33.3%-11.0pp
Net margin-30.9%-10.5pp
FCF margin-77.4%+35.3pp

Returns & leverage

See full
Return on equity-67.6%-20.3pp
Debt / equity1.4×+1.1×
Current ratio4.1×-5.6×

Where this comes from

Reported directly by Ionis Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit.

The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ionis Pharmaceuticals's state.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ionis Pharmaceuticals's state?
Ionis Pharmaceuticals (IONS) reported state of $0 in Q4 2025.
What does state mean?
Non-cash state and local tax impacts resulting from timing differences between accounting and tax rules.
How do you interpret state?
Fluctuations indicate changes in the timing of deductions or income recognition for state tax purposes.
How does state compare across companies?
Standard component of the deferred tax reconciliation in financial statements.